Nuveen, LLC Summit Therapeutics Inc. Transaction History
Nuveen, LLC
- $315 Billion
- Q1 2025
A detailed history of Nuveen, LLC transactions in Summit Therapeutics Inc. stock. As of the latest transaction made, Nuveen, LLC holds 235,893 shares of SMMT stock, worth $4.92 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
235,893Holding current value
$4.92 Million% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding SMMT
# of Institutions
236Shares Held
86.8MCall Options Held
1.84MPut Options Held
3.13M-
Baker Bros. Advisors LP New York, NY24.4MShares$509 Million5.62% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.6MShares$243 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.9MShares$165 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.56MShares$137 Million0.02% of portfolio
-
State Street Corp Boston, MA4.85MShares$101 Million0.0% of portfolio
About Summit Therapeutics Inc.
- Ticker SMMT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 201,215,008
- Market Cap $4.2B
- Description
- Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecu...